The Potential of N-Acetylcysteine for Treatment of Trichotillomania, Excoriation Disorder, Onychophagia, and Onychotillomania: An Updated Literature Review.
Lee DK, Lipner SR.
Int J Environ Res Public Health. 2022 May 24;19(11):6370. doi: 10.3390/ijerph19116370.
Onychotillomania: Diagnosis and Management.
Halteh P, Scher RK, Lipner SR.
Am J Clin Dermatol. 2017 Dec;18(6):763-770. doi: 10.1007/s40257-017-0289-6.
Update on Diagnosis and Management of Onychophagia and Onychotillomania.
Lee DK, Lipner SR.
Int J Environ Res Public Health. 2022 Mar 13;19(6):3392. doi: 10.3390/ijerph19063392.
Onychotillomania: An underrecognized disorder.
Rieder EA, Tosti A.
J Am Acad Dermatol. 2016 Dec;75(6):1245-1250. doi: 10.1016/j.jaad.2016.05.036. Epub 2016 Jul 26.
Onychotillomania in the Setting of Homelessness.
Rasul TF, Gulraiz S, Henderson A.
Cureus. 2022 Mar 9;14(3):e22988. doi: 10.7759/cureus.22988. eCollection 2022 Mar.
Onychotillomania.
Colver GB.
Br J Dermatol. 1987 Sep;117(3):397-9. doi: 10.1111/j.1365-2133.1987.tb04150.x.
Onychotillomania: clinicopathologic correlations.
Reese JM, Hudacek KD, Rubin AI.
J Cutan Pathol. 2013 Apr;40(4):419-23. doi: 10.1111/cup.12098. Epub 2013 Feb 12.
Smith-Magenis Syndrome.
Smith ACM, Boyd KE, Brennan C, Charles J, Elsea SH, Finucane BM, Foster R, Gropman A, Girirajan S, Haas-Givler B.
2001 Oct 22 [updated 2022 Mar 10]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Onychotillomania: A Chameleon-Like Disorder: Case Report and Review of Literature.
Sidiropoulou P, Sgouros D, Theodoropoulos K, Katoulis A, Rigopoulos D.
Skin Appendage Disord. 2019 Feb;5(2):104-107. doi: 10.1159/000489941. Epub 2018 Jun 25.
Oral N-acetylcysteine in the treatment of Onychotillomania.
Nguyen B, Hawash AA, Tosti A.
Dermatol Ther. 2022 Aug;35(8):e15605. doi: 10.1111/dth.15605. Epub 2022 Jun 7.
